Chris Bahl

After finishing my PhD in Biochemistry from the MCB program at the Geisel School of Medicine, I did a postdoctoral fellowship at the University of Washington's Institute for Protein Design in Seattle.  Next, I joined the Institute for Protein Innovation in Boston where I was the Head of Protein Design.  At the IPI, I led an academic research group that paired computational de novo protein design with high-throughput protein biochemistry and biophysics.  We developed a novel drug discovery platform, which we spun out into a biotech company called AI Proteins, where I am the Chief Scientific Officer and Co-founder.  I'm also a part-time Lecturer at Boston Children's Hospital and Harvard Medical School.